JPH0566952B2 - - Google Patents

Info

Publication number
JPH0566952B2
JPH0566952B2 JP60083297A JP8329785A JPH0566952B2 JP H0566952 B2 JPH0566952 B2 JP H0566952B2 JP 60083297 A JP60083297 A JP 60083297A JP 8329785 A JP8329785 A JP 8329785A JP H0566952 B2 JPH0566952 B2 JP H0566952B2
Authority
JP
Japan
Prior art keywords
group
acid addition
pyrimidinyl
substituted
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60083297A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61238784A (ja
Inventor
Kikuo Ishizumi
Fujio Antoku
Isamu Maruyama
Atsuyuki Kojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Priority to JP60083297A priority Critical patent/JPS61238784A/ja
Priority to CA000506643A priority patent/CA1268459A/en
Priority to AT86105299T priority patent/ATE56006T1/de
Priority to EP86105299A priority patent/EP0200968B1/en
Priority to DE8686105299T priority patent/DE3673688D1/de
Publication of JPS61238784A publication Critical patent/JPS61238784A/ja
Priority to US07/182,085 priority patent/US4843078A/en
Publication of JPH0566952B2 publication Critical patent/JPH0566952B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/72—4,7-Endo-alkylene-iso-indoles
    • C07D209/76—4,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
JP60083297A 1985-04-17 1985-04-17 コハク酸イミド誘導体及びその酸付加塩 Granted JPS61238784A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP60083297A JPS61238784A (ja) 1985-04-17 1985-04-17 コハク酸イミド誘導体及びその酸付加塩
CA000506643A CA1268459A (en) 1985-04-17 1986-04-15 Succinimide derivatives, and their production and use
AT86105299T ATE56006T1 (de) 1985-04-17 1986-04-17 Succinimide derivate, herstellung und anwendung.
EP86105299A EP0200968B1 (en) 1985-04-17 1986-04-17 Succinimide derivatives, their production and use
DE8686105299T DE3673688D1 (de) 1985-04-17 1986-04-17 Succinimide derivate, herstellung und anwendung.
US07/182,085 US4843078A (en) 1985-04-17 1988-04-15 Succinimide derivatives, and their production and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60083297A JPS61238784A (ja) 1985-04-17 1985-04-17 コハク酸イミド誘導体及びその酸付加塩

Publications (2)

Publication Number Publication Date
JPS61238784A JPS61238784A (ja) 1986-10-24
JPH0566952B2 true JPH0566952B2 (OSRAM) 1993-09-22

Family

ID=13798462

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60083297A Granted JPS61238784A (ja) 1985-04-17 1985-04-17 コハク酸イミド誘導体及びその酸付加塩

Country Status (6)

Country Link
US (1) US4843078A (OSRAM)
EP (1) EP0200968B1 (OSRAM)
JP (1) JPS61238784A (OSRAM)
AT (1) ATE56006T1 (OSRAM)
CA (1) CA1268459A (OSRAM)
DE (1) DE3673688D1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4892943A (en) * 1985-10-16 1990-01-09 American Home Products Corporation Fused bicyclic imides with psychotropic activity
DD263531A5 (de) * 1986-10-21 1989-01-04 ������@���Kk�� Verfahren zur herstellung von verbrueckten bicyclischen imidverbindungen
US4804751A (en) * 1987-06-30 1989-02-14 American Home Products Corporation Polycyclic hydrocarbon succinimides with psychotropic activity
US5053508A (en) * 1990-03-09 1991-10-01 American Home Products Corporation Fused heterotricyclic imides with psychotropic activity and intermedrates thereof
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
CN101693697A (zh) * 2003-07-30 2010-04-14 泽农医药公司 哌嗪衍生物和它们作为治疗剂的用途
US20090318515A1 (en) * 2005-11-21 2009-12-24 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
US8853257B2 (en) 2005-11-21 2014-10-07 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
CL2008000467A1 (es) 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
WO2011030139A1 (en) * 2009-09-11 2011-03-17 Astrazeneca Ab 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
ES2683127T3 (es) 2013-10-17 2018-09-25 Blueprint Medicines Corporation Composiciones útiles para tratar trastornos relacionados con la KIT
CN113633637A (zh) * 2016-01-13 2021-11-12 四川科瑞德制药股份有限公司 一种氮杂螺酮类药物组合物及其制备方法
LT3856341T (lt) 2019-04-12 2023-12-27 Blueprint Medicines Corporation (s)-1-(4-fluorfenil)-1-(2-(4-(6-(1-metil-1h-pirazol-4-il)pirolo[2,1-f] [1,2,4]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amino kristalinės formos ir gamybos būdai
AU2020272743B2 (en) 2019-04-12 2025-10-16 Blueprint Medicines Corporation Pyrrolotriazine derivatives for treating KIT- and PDGFRa-mediated diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2672460A (en) * 1952-06-24 1954-03-16 American Cyanamid Co Disubstituted piperazines and methods of preparing the same
JPS57197265A (en) * 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
JPS5995267A (ja) * 1982-11-25 1984-06-01 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4562255A (en) * 1984-03-30 1985-12-31 American Home Products Corporation Substituted bi-alicyclic imides

Also Published As

Publication number Publication date
EP0200968B1 (en) 1990-08-29
JPS61238784A (ja) 1986-10-24
CA1268459A (en) 1990-05-01
US4843078A (en) 1989-06-27
EP0200968A1 (en) 1986-11-12
ATE56006T1 (de) 1990-09-15
DE3673688D1 (de) 1990-10-04

Similar Documents

Publication Publication Date Title
JP2781662B2 (ja) Ｃｒｆアンタゴニスト活性を有するアミノ置換ピラゾール
JPH0566952B2 (OSRAM)
EP0082402B1 (en) Succinimide derivates and process for preparation thereof
US9550735B2 (en) Process for the preparation of ivacaftor and solvates thereof
EP1497274A2 (fr) Derives de terphenyle, leur preparation, les compositions pharmaceutiques en contenant
GB1563398A (en) 4-(alkoxyphenyo)-2-pyrrolidones
WO2003084930A1 (fr) Derives de diphenylpyridine, leur preparation, les compositions pharmaceutiques en contenant
KR20060130126A (ko) 1-피페라진- 및 1-호모피페라진-카르복실레이트의 유도체,이의 제법 및 치료 용도
CN109485638B (zh) 一种奥希替尼中间体的制备方法
HU215394B (hu) 3-Fenil-izokinolin-1(2H)-on-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
TWI249533B (en) Pyridazin-3-one derivatives and medicines containing the same
EP0012208B1 (en) 9-(3-(3,5-cis-dimethylpiperazino)propyl)-carbazole, its preparation and pharmaceutical compositions containing it
EP0111226B1 (en) Carboximide derivatives, process for their production and medicines containing same
JP4659984B2 (ja) 精神障害の処置のための３−テトラヒドロピリジン−４−イルインドール類
SK282234B6 (sk) Spôsob výroby n-metyl-3-(1-metyl-4-piperidinyl)-1h-indol-5-etánsulfónamidu a medziprodukt
WO2004014876A1 (en) Urea derivatives as kinase inhibitors
EP0591027A1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
EP0664799A1 (en) Amide derivatives
WO1984000962A1 (fr) DERIVES D'INDENO AD1,2-b BD PYRROLE
US4716159A (en) Pyridazino[4,3-c]-isoquinolines having anti-anxiety activity
JPH0220638B2 (OSRAM)
FR2534255A1 (fr) Nouveaux derives de la 4-aroylamino piperidine, leur procede de preparation et leur application en therapeutique
JPH083167A (ja) ピラゾロ〔１，５−ａ〕ピリミジン誘導体
CN117858866A (zh) 用于制备色胺衍生物的方法
JP4204808B2 (ja) １−置換インドール類の製造方法